Structure and design of Langya virus glycoprotein antigens
暂无分享,去创建一个
C. Broder | D. Veesler | Young-Jun Park | M. McCallum | Lianying Yan | Zhaoqian Wang | H. Dang | Ashley E. Person | Moushimi Amaya | William K. Sharkey
[1] David J. Fleet,et al. 3D Flexible Refinement: Determining Structure and Motion of Flexible Proteins from Cryo-EM. , 2023, Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada.
[2] Cassandra L. Pegg,et al. Structure and antigenicity of divergent Henipavirus fusion glycoproteins , 2023, Nature communications.
[3] L. Käll,et al. Automated model building and protein identification in cryo-EM maps , 2023, bioRxiv.
[4] P. Acharya,et al. Structures of Langya Virus Fusion Protein Ectodomain in Pre- and Postfusion Conformation , 2023, bioRxiv.
[5] David J. Fleet,et al. 3DFlex: determining structure and motion of flexible proteins from cryo-EM , 2023, Nature Methods.
[6] S. Madhi,et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. , 2023, The New England journal of medicine.
[7] E. Walsh,et al. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults. , 2023, The New England journal of medicine.
[8] L. M. Casseb,et al. First Genomic Evidence of a Henipa-like Virus in Brazil , 2022, Viruses.
[9] Yue Li,et al. A Zoonotic Henipavirus in Febrile Patients in China. , 2022, The New England journal of medicine.
[10] J. Derisi,et al. Discovery and Genomic Characterization of a Novel Henipavirus, Angavokely virus, from fruit bats in Madagascar , 2022, bioRxiv.
[11] B. Sankaran,et al. Robust deep learning based protein sequence design using ProteinMPNN , 2022, bioRxiv.
[12] C. Broder,et al. Potent monoclonal antibody–mediated neutralization of a divergent Hendra virus variant , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[13] Noam Brown,et al. Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in Australia , 2022, Emerging infectious diseases.
[14] C. Broder,et al. Architecture and antigenicity of the nipah virus attachment glycoprotein , 2022, Biophysical Journal.
[15] T. Klein,et al. Discovery and Genetic Characterization of Novel Paramyxoviruses Related to the Genus Henipavirus in Crocidura Species in the Republic of Korea , 2021, Viruses.
[16] C. Broder,et al. Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein , 2021, Cell reports.
[17] Oriol Vinyals,et al. Highly accurate protein structure prediction with AlphaFold , 2021, Nature.
[18] David T. Williams,et al. A new Hendra virus genotype found in Australian flying foxes , 2021, Virology Journal.
[19] C. Broder,et al. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins , 2021, Nature Structural & Molecular Biology.
[20] J. Epstein,et al. Functional Analysis of the Fusion and Attachment Glycoproteins of Mojiang Henipavirus , 2021, Viruses.
[21] J. Mascola,et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.
[22] P. Dormitzer,et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.
[23] J. Crowe,et al. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein , 2020, Cell.
[24] Lisa E. Gralinski,et al. Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2. Walls, Fiala et al. , 2020 .
[25] C. Broder,et al. Vaccines to Emerging Viruses: Nipah and Hendra. , 2020, Annual review of virology.
[26] Rebecca J. Loomis,et al. SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness , 2020, Nature.
[27] J. Mascola,et al. Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development , 2020, Frontiers in Immunology.
[28] Benjamin S. Hughes,et al. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. , 2020, The Lancet. Infectious diseases.
[29] David J. Fleet,et al. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction , 2019, Nature Methods.
[30] C. Broder,et al. Optimization and Diagnostic Evaluation of Monoclonal Antibody-based Blocking ELISA Formats for Detection of Neutralizing Antibodies to Hendra Virus in Mammalian Sera. , 2019, Journal of virological methods.
[31] Sergei L. Kosakovsky Pond,et al. A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex , 2019, Proceedings of the National Academy of Sciences.
[32] Paul Emsley,et al. Current developments in Coot for macromolecular model building of Electron Cryo‐microscopy and Crystallographic Data , 2019, Protein science : a publication of the Protein Society.
[33] C. Broder,et al. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection , 2019, The Journal of infectious diseases.
[34] Sjors H.W. Scheres,et al. Faculty Opinions recommendation of Real-time cryo-electron microscopy data preprocessing with Warp. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[35] Christopher J. Williams,et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix , 2019, Acta crystallographica. Section D, Structural biology.
[36] C. Broder,et al. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections , 2019, Nature Structural & Molecular Biology.
[37] C. Broder,et al. Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus , 2019, Proceedings of the National Academy of Sciences.
[38] I. Rissanen,et al. A key region of molecular specificity orchestrates unique ephrin-B1 utilization by Cedar virus , 2019, Life Science Alliance.
[39] A. Walls,et al. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion , 2019, Cell.
[40] Erik Lindahl,et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.
[41] Jared Adolf-Bryfogle,et al. Automatically Fixing Errors in Glycoprotein Structures with Rosetta , 2018, Structure.
[42] Jasenko Zivanov,et al. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis , 2018, bioRxiv.
[43] D. Mastronarde. Advanced Data Acquisition From Electron Microscopes With SerialEM , 2018, Microscopy and Microanalysis.
[44] Tristan Ian Croll,et al. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps , 2018, Acta crystallographica. Section D, Structural biology.
[45] Conrad C. Huang,et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis , 2018, Protein science : a publication of the Protein Society.
[46] A. Walls,et al. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion , 2017, Proceedings of the National Academy of Sciences.
[47] Barney S. Graham,et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen , 2017, Proceedings of the National Academy of Sciences.
[48] I. Rissanen,et al. Idiosyncratic Mòjiāng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses , 2017, Nature Communications.
[49] David J. Fleet,et al. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.
[50] Frank DiMaio,et al. Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta , 2016, bioRxiv.
[51] F. Dimaio,et al. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer , 2016, Nature.
[52] R. Lamb,et al. Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form , 2015, Proceedings of the National Academy of Sciences.
[53] C. Broder,et al. Crystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers Assembly , 2015, PLoS pathogens.
[54] Keith S Wilson,et al. Privateer: software for the conformational validation of carbohydrate structures , 2015, Nature Structural &Molecular Biology.
[55] R. Cattaneo,et al. A Structurally Unresolved Head Segment of Defined Length Favors Proper Measles Virus Hemagglutinin Tetramerization and Efficient Membrane Fusion Triggering , 2015, Journal of Virology.
[56] A. Zeltiña,et al. Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus , 2015, Proceedings of the National Academy of Sciences.
[57] Matthias J. Brunner,et al. Atomic accuracy models from 4.5 Å cryo-electron microscopy data with density-guided iterative local refinement , 2015, Nature Methods.
[58] Lori A. Passmore,et al. Ultrastable gold substrates for electron cryomicroscopy , 2014, Science.
[59] P. Daszak,et al. Evidence for henipavirus spillover into human populations in Africa , 2014, Nature Communications.
[60] C. Broder,et al. Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody , 2014, Science Translational Medicine.
[61] Q. Jin,et al. Novel Henipa-like Virus, Mojiang Paramyxovirus, in Rats, China, 2012 , 2014, Emerging infectious diseases.
[62] C. Broder,et al. Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health , 2014, Emerging infectious diseases.
[63] C. Broder,et al. A Recombinant Hendra Virus G Glycoprotein Subunit Vaccine Protects Nonhuman Primates against Hendra Virus Challenge , 2014, Journal of Virology.
[64] R. Henderson,et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy☆ , 2013, Ultramicroscopy.
[65] Cinque S. Soto,et al. Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus , 2013, Science.
[66] U. Baxa,et al. Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody , 2013, Science.
[67] R. Lamb,et al. Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein , 2012, Proceedings of the National Academy of Sciences.
[68] C. Broder,et al. Biochemical, Conformational, and Immunogenic Analysis of Soluble Trimeric Forms of Henipavirus Fusion Glycoproteins , 2012, Journal of Virology.
[69] A. Huang,et al. N-Glycans on the Nipah Virus Attachment Glycoprotein Modulate Fusion and Viral Entry as They Protect against Antibody Neutralization , 2012, Journal of Virology.
[70] Heinz Feldmann,et al. A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge , 2012, Science Translational Medicine.
[71] C. D. de Jong,et al. Cedar Virus: A Novel Henipavirus Isolated from Australian Bats , 2012, PLoS pathogens.
[72] Oscar A. Negrete,et al. Cysteines in the Stalk of the Nipah Virus G Glycoprotein Are Located in a Distinct Subdomain Critical for Fusion Activation , 2012, Journal of Virology.
[73] C. Broder,et al. A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge , 2011, Science Translational Medicine.
[74] C. Broder,et al. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. , 2011, Vaccine.
[75] P. Kwong,et al. Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes , 2011, Journal of Virology.
[76] C. Mandl,et al. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers , 2011, Proceedings of the National Academy of Sciences.
[77] Benhur Lee,et al. A Quantitative and Kinetic Fusion Protein-Triggering Assay Can Discern Distinct Steps in the Nipah Virus Membrane Fusion Cascade , 2010, Journal of Virology.
[78] Herren Wu,et al. Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit Fusion , 2010, Journal of Virology.
[79] Vincent B. Chen,et al. MolProbity: all-atom structure validation for macromolecular crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.
[80] C. Broder,et al. A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection , 2009, PLoS pathogens.
[81] C. Broder,et al. Preparation of Recombinant Viral Glycoproteins for Novel and Therapeutic Antibody Discovery , 2008, Methods in molecular biology.
[82] C. Broder,et al. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats , 2008, Vaccine.
[83] C. Broder,et al. Exceptionally Potent Cross-Reactive Neutralization of Nipah and Hendra Viruses by a Human Monoclonal Antibody , 2008, The Journal of infectious diseases.
[84] M. Georges-Courbot,et al. Henipavirus and Tioman Virus Antibodies in Pteropodid Bats, Madagascar , 2007, Emerging infectious diseases.
[85] C. Broder,et al. Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine , 2006, Journal of Virology.
[86] R. Lamb,et al. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation , 2006, Nature.
[87] R. Dutch,et al. Cathepsin L Is Involved in Proteolytic Processing of the Hendra Virus Fusion Protein , 2005, Journal of Virology.
[88] H. Klenk,et al. The Nipah Virus Fusion Protein Is Cleaved within the Endosomal Compartment* , 2005, Journal of Biological Chemistry.
[89] Lin-Fa Wang,et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[90] Oscar A. Negrete,et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus , 2005, Nature.
[91] Anchi Cheng,et al. Automated molecular microscopy: the new Leginon system. , 2005, Journal of structural biology.
[92] R. Lamb,et al. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[93] R. Dutch,et al. Role of N-Linked Glycosylation of the Hendra Virus Fusion Protein , 2005, Journal of Virology.
[94] C. Broder,et al. Receptor Binding, Fusion Inhibition, and Induction of Cross-Reactive Neutralizing Antibodies by a Soluble G Glycoprotein of Hendra Virus , 2005, Journal of Virology.
[95] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[96] R. Henderson,et al. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. , 2003, Journal of molecular biology.
[97] David N. Mastronarde,et al. SerialEM: A Program for Automated Tilt Series Acquisition on Tecnai Microscopes Using Prediction of Specimen Position , 2003, Microscopy and Microanalysis.
[98] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[99] C. Broder,et al. Hendra and Nipah viruses: different and dangerous , 2006, Nature Reviews Microbiology.